CARMEL,
Ind., Feb. 8, 2024 /PRNewswire/ -- Syra Health
Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare
technology company addressing some of healthcare's most significant
challenges by providing innovative services and technology
solutions, announced today that it has been selected as a
subcontractor for a contract awarded to Caduceus Healthcare, Inc.
by the federal Department of Health and Human Services (HHS),
Administration for Families and Children (ACR), Office of Refugee
Resettlement (ORR) Medical Staffing and Support, valued at
$75 billion.
Syra Health will provide multiple services to Georgia-based Caduceus Healthcare, Inc., which
is the prime contractor in support of this multi-billion-dollar
Federal Influx Care Facilities contract.
The contract establishes a multiple-award vehicle for providing
temporary shelter, care facilities, direct care services, medical
care, case management, education, and transportation in support of
HHS's Influx Care Facilities.
"Syra is honored to be part of this important federal contract
to help ensure the welfare, health, and safety of children through
this important program," said Sandeep
Allam, Executive Chairman and President, Syra Health. "We look forward to a long-standing
partnership with Caduceus Healthcare in fulfillment of this
multi-year contract."
Syra Health has served as a trusted partner to state and local
governments offering specialized services catered specifically to
the diverse needs of government healthcare. Syra's solutions ensure
efficient management, cost-effectiveness, and accessible healthcare
delivery. Syra Health announced the launch of its federal
government solutions business unit in December of 2023 to build
upon its years of service in the state and local government
sector.
"We are thrilled about the rapid success of our federal
government solutions through this partnership that has awarded us
our first federal-based contract," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "Our ability to service local,
state, and now federal agency agreements, provides us with
broadened capabilities and experience that will serve us well as we
continue to bid on additional federal contracts."
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some
of healthcare's most significant challenges in areas such
as behavioral and mental health, digital health,
and population health, by providing innovative services and
technology solutions. Syra Health's products and services are
centered on prevention, improved access, and affordable care. Syra
Health supplies its solutions to payers, providers, life sciences
organizations, academic institutions, and the government. For more
information, please visit www.syrahealth.com.
FORWARD-LOOKING STATEMENTS
Statements in this press release about future expectations,
plans, and prospects, as well as any other statements regarding
matters that are not historical facts, may constitute
"forward-looking statements." These statements include, but are not
limited to, statements relating to the expected use of proceeds,
the Company's operations and business strategy and the Company's
expected financial results. The words "anticipate," "believe,"
"continue," "could," "estimate," "expect," "intend," "may," "plan,"
"potential," "predict," "project," "should," "target," "will,"
"would" and similar expressions are intended to identify
forward-looking statements, although not all forward-looking
statements contain these identifying words. The forward-looking
statements contained in this press release are based on
management's current expectations and are subject to substantial
risks, uncertainty and changes in circumstances. Investors should
read the risk factors set forth in our registration statement on
Form S-1 and other periodic reports filed with the Securities and
Exchange Commission. Any forward-looking statements contained in
this press release speak only as of the date hereof, and, except as
required by federal securities laws, the Company specifically
disclaims any obligation to update any forward-looking statements,
whether as a result of new information, future events, or
otherwise.
For more information, please contact:
For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/syra-health-announces-partnership-for-a-federal-contract-valued-at-75-billion-302057576.html
SOURCE Syra Health